Screening for cancer: Lessons learned from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial - Abstract

While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial make the trial a success.

Written by:
Grubb RL, Pinsky P, Prorok PC, Andriole GL.   Are you the author?
Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.  

Reference: Eur Urol. 2015 May 7. pii: S0302-2838(15)00328-0.
doi: 10.1016/j.eururo.2015.04.026


PubMed Abstract
PMID: 25959167

UroToday.com Prostate Cancer Section